Microbiology

  1. Saliva sampling is an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supply shortages

    1. Joaquín Moreno-Contreras
    2. Marco A. Espinoza
    3. Carlos Sandoval-Jaime
    4. Marco A. Cantú-Cuevas
    5. Héctor Barón-Olivares
    6. Oscar D. Ortiz-Orozco
    7. Asunción V. Muñoz-Rangel
    8. Manuel Hernández-de la Cruz
    9. César M. Eroza-Osorio
    10. Carlos F. Arias
    11. Susana López

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Nanotrap ® particles improve detection of SARS-CoV-2 for pooled sample methods, extraction-free saliva methods, and extraction-free transport medium methods

    1. RA Barclay
    2. I Akhrymuk
    3. A Patnaik
    4. V Callahan
    5. C Lehman
    6. P Andersen
    7. R Barbero
    8. S Barksdale
    9. R Dunlap
    10. D Goldfarb
    11. T Jones-Roe
    12. R Kelly
    13. B Kim
    14. S Miao
    15. A Munns
    16. D Munns
    17. S Patel
    18. E Porter
    19. R Ramsey
    20. S Sahoo
    21. O Swahn
    22. J Warsh
    23. K Kehn-Hall
    24. B Lepene

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Using nucleocapsid proteins to investigate the relationship between SARS-CoV-2 and closely related bat and pangolin coronaviruses

    1. Noah Schuster

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Ag nanoparticles-based antimicrobial polycotton fabrics to prevent the transmission and spread of SARS-CoV-2

    1. Guilherme C. Tremiliosi
    2. Luiz Gustavo P. Simoes
    3. Daniel T. Minozzi
    4. Renato I. Santos
    5. Daiane C. B. Vilela
    6. Edison Luiz Durigon
    7. Rafael Rahal Guaragna Machado
    8. Douglas Sales Medina
    9. Lara Kelly Ribeiro
    10. Ieda Lucia Viana Rosa
    11. Marcelo Assis
    12. Juan Andrés
    13. Elson Longo
    14. Lucio H. Freitas-Junior

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Antiviral Drug Screen of Kinase inhibitors Identifies Cellular Signaling Pathways Critical for SARS-CoV-2 Replication

    1. Gustavo Garcia
    2. Arun Sharma
    3. Arunachalam Ramaiah
    4. Chandani Sen
    5. Donald Kohn
    6. Brigitte Gomperts
    7. Clive N. Svendsen
    8. Robert D Damoiseaux
    9. Vaithilingaraja Arumugaswami

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Comparison of 12 molecular detection assays for SARS-CoV-2

    1. Yasufumi Matsumura
    2. Tsunehiro Shimizu
    3. Taro Noguchi
    4. Satoshi Nakano
    5. Masaki Yamamoto
    6. Miki Nagao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Phylogenomics reveals viral sources, transmission, and potential superinfection in early-stage COVID-19 patients in Ontario, Canada

    1. Calvin P. Sjaarda
    2. Nazneen Rustom
    3. Gerald A. Evans
    4. David Huang
    5. Santiago Perez-Patrigeon
    6. Melissa L. Hudson
    7. Henry Wong
    8. Zhengxin Sun
    9. T. Hugh Guan
    10. Muhammad Ayub
    11. Claudio N. Soares
    12. Robert I. Colautti
    13. Prameet M. Sheth

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Development of a fluorescence based, high-throughput SARS-CoV-2 3CL pro reporter assay

    1. Heather M. Froggatt
    2. Brook E. Heaton
    3. Nicholas S. Heaton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Evaluation of Different PCR Assay Formats for Sensitive and Specific Detection of SARS-CoV-2 RNA

    1. Jeremy Ratcliff
    2. Dung Nguyen
    3. Monique Andersson
    4. Peter Simmonds

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. In silico Identification of Conserved cis -acting Rna Elements in the SARS-CoV-2 Genome

    1. Bader Y Alhatlani

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 52 of 251 Next